Verition Fund Management
ALBO

Verition Fund Management’s Albireo Pharma Inc ALBO Stock Holding History

Verition Fund Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,797
Closed -$405K – 1843
2020
Q4 		$405K Sell
10,797
-32,111
-75% -$1.17M ﹤0.01% 727
2020
Q3 		$1.43M Buy
+42,908
New +$1.25M 0.03% 307

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Verition Fund Management's ALBO Position: Q1 2021 in Review

Verition Fund Management sold out of Albireo Pharma Inc (ALBO) in Q1 2021, closing a stake of 10,797 shares — an estimated $405K sold.

Verition Fund Management first reported a position in ALBO in Q3 2020 and held it in 2 quarters. The position peaked at $1.43M in Q3 2020. 100 funds tracked by Wall St. Rank hold ALBO as of Q1 2021.

  • Verition Fund Management reported no remaining Albireo Pharma Inc position as of Q1 2021 after selling out during the quarter.
  • Verition Fund Management sold 10,797 Albireo Pharma Inc shares in Q1 2021, an estimated $405K.
  • Verition Fund Management first reported a position in Albireo Pharma Inc in Q3 2020 and held it in 2 quarters.
  • Verition Fund Management's Albireo Pharma Inc position peaked at $1.43M in Q3 2020.
  • 100 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2021.

Based on Verition Fund Management's 13F filing for Q1 2021, filed 18 May 2021.